Women up, men down: the clinical impact of replacing the Framingham Risk Score with the Reynolds Risk Score in the United States population.

by Matthew C Tattersall, Ronald E Gangnon, Kunal N Karmali, Jon G Keevil
Published 2012-01-01

Point-of-care testing to promote cardiovascular disease risk assessment: A proof of concept study

by Kunal N. Karmali, Tiffany Brown, Thomas Sanchez, Timothy Long, Stephen D. Persell
Published 2017-09-01

Trends in low-density lipoprotein cholesterol goal achievement in high risk United States adults: longitudinal findings from the 1999-2008 National Health and Nutrition Examination...

by Matthew C Tattersall, Ronald E Gangnon, Kunal N Karmali, Michael W Cullen, James H Stein, Jon G Keevil
Published 2013-01-01

Implementation and acceptability of a heart attack quality improvement intervention in India: a mixed methods analysis of the ACS QUIK trial

by Kavita Singh, Raji Devarajan, Padinhare P. Mohanan, Abigail S. Baldridge, Dimple Kondal, David E. Victorson, Kunal N. Karmali, Lihui Zhao, Donald M. Lloyd-Jones, Dorairaj Prabhakaran, Shifalika Goenka, Mark D. Huffman, on behalf of the ACS QUIK Investigators
Published 2019-02-01

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.

by Kunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, David C Goff, Salim Yusuf, Alberto Zanchetti, Paul Glasziou, Rodney Jackson, Mark Woodward, Anthony Rodgers, Bruce C Neal, Eivind Berge, Koon Teo, Barry R Davis, John Chalmers, Carl Pepine, Kazem Rahimi, Johan Sundström, Blood Pressure Lowering Treatment Trialists’ Collaboration
Published 2018-03-01